Equity Analysis /
United States of America

US : REGENXBIO Inc. - RGNX | 1Q22 Financial Results and Delay on Initiation of Ph 1/2 Trial of RGX-202

    Dane Leone
    CGS-CIMB
    5 May 2022
    Published by